Follow
Ritwik Sinha
Title
Cited by
Cited by
Year
Artificial intelligence: How is it changing medical sciences and its future?
K Basu, R Sinha, A Ong, T Basu
Indian journal of dermatology 65 (5), 365-370, 2020
2382020
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who …
K Porkka, HJ Khoury, RL Paquette, Y Matloub, R Sinha, JE Cortes
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
2122010
Dasatinib 2-year efficacy in patients with chronic-phase chronic myelogenous leukemia (CML-CP) with resistance or intolerance to imatinib (START-C)
MJ Mauro, M Baccarani, F Cervantes, JH Lipton, Y Matloub, R Sinha, ...
Journal of Clinical Oncology 26 (15_suppl), 7009-7009, 2008
1012008
Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study
BA Rybicki, R Sinha, S Iyengar, C Gray-McGuire, RC Elston, MC Iannuzzi
Genes & Immunity 8 (5), 379-386, 2007
572007
Predicting reactions to short-text posts
BV Srinivasan, A Natarajan, R Sinha, V Gupta, SV Revankar, B Ravindran
US Patent 9,256,826, 2016
482016
Time-uniform central limit theory and asymptotic confidence sequences
I Waudby-Smith, D Arbour, R Sinha, EH Kennedy, A Ramdas
The Annals of Statistics 52 (6), 2613-2640, 2024
45*2024
Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5
C Gray-McGuire, R Sinha, S Iyengar, C Millard, BA Rybicki, RC Elston, ...
Human genetics 120, 420-430, 2006
402006
Dasatinib time to and durability of major and complete cytogenetic response (MCyR and CCyR) in patients with chronic myeloid leukemia in chronic phase (CML-CP)
M Baccarani, G Rosti, G Saglio, J Cortes, R Stone, DW Niederwieser, ...
Blood 112 (11), 450, 2008
392008
Saliency prediction for a mobile user interface
P Gupta, S Pal, S Gupta, R Sinha, A Jayagopal
US Patent 10,664,999, 2020
372020
Optimal time to post for maximum social engagement
BV Srinivasan, N Anandhavelu, R Sinha, S Revankar
US Patent 9,607,273, 2017
362017
Identifying sources of anomalies in multi-variable metrics using linearization
SK Saini, R Sinha, M Rimer, N Anandhavelu
US Patent 10,404,777, 2019
312019
A non-parametric approach to the multi-channel attribution problem
MM Yadagiri, SK Saini, R Sinha
Web Information Systems Engineering–WISE 2015: 16th International Conference …, 2015
272015
Probabilistic deduplication of anonymous web traffic
R Saha Roy, R Sinha, N Chhaya, S Saini
Proceedings of the 24th International Conference on World Wide Web, 103-104, 2015
232015
Marketing channel attribution
R Sinha, SK Saini, N Anandhavelu
US Patent App. 14/508,141, 2016
222016
Estimating the incremental effects of interactions for marketing attribution
R Sinha, S Saini, N Anadhavelu
2014 International Conference on Behavioral, Economic, and Socio-Cultural …, 2014
222014
A mathematical abstraction for balancing the trade-off between creativity and reality in large language models
R Sinha, Z Song, T Zhou
arXiv preprint arXiv:2306.02295, 2023
212023
Saliency prediction for mobile user interfaces
P Gupta, S Gupta, A Jayagopal, S Pal, R Sinha
2018 IEEE Winter Conference on Applications of Computer Vision (WACV), 1529-1538, 2018
192018
Dasatinib-Associated Major Molecular Responses Are Rapidly Achieved in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Following Resistance, Suboptimal …
A Hochhaus, MC Müller, J Radich, S Branford, B Hanfstein, P Rousselot, ...
Blood 112 (11), 1095, 2008
192008
Multiple testing in the genomics era: findings from Genetic Analysis Workshop 15, Group 15
LJ Martin, JG Woo, CL Avery, HS Chen, KE North, Group 15
Genetic Epidemiology 31 (S1), S124-S131, 2007
182007
Will your facebook post be engaging?
BV Srinivasan, A Natarajan, R Sinha, V Gupta, S Revankar, B Ravindran
Proceedings of the 1st workshop on User engagement optimization, 25-28, 2013
172013
The system can't perform the operation now. Try again later.
Articles 1–20